Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

Medicine results for "ESTRADIOL VALERATE" 2 medicines in Tanzania

0 selected

Price column visibility: locked (sign in required)

Page 1 of 1

	Reg No.	Product Name	Active Ingredient	Manufacturer	Status
	TAN 00,4244 G03A N.V	Norigynon	Estradiol valerate 5 mg/5.26ml,Norethisterone Enantate 50 mg/5.26ml	Bayer de México, S. A. de C. V.	Registered/Compliant	Details →
	TAN 26 HM 0471	Qlaira	Dienogest (Light yellow tablets) 3 mg,Dienogest (medium red tablets) 2 mg,Dienogest, micronized (for Phase 2 of the FPP) 2.000 mg,Dienogest, micronized (for Phase 3 of the FPP) 3.000 mg,Estradiol valerate (Dark red tablets) 1 mg,Estradiol valerate (Light yellow tablets) 2 mg,Estradiol valerate (dark yellow tablets) 3 mg,Estradiol valerate (medium red tablets) 2 mg,Estradiol valerate, micronized (for Phase 1 of the FPP) 3.000 mg,Estradiol valerate, micronized (for Phase 2 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 3 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 4 of the FPP) 1.000 mg,Ferric oxide, red (for Phase 2 of the FPP) 0.03906 mg,Ferric oxide, red (for Phase 4 of the FPP) 0.3651 mg,Ferric oxide, yellow (for Phase 1 of the FPP) 0.2920 mg,Ferric oxide, yellow (for Phase 3 of the FPP) 0.03906 mg,Hypromellose 5 cP (for Phases 1, 2, 3 and 4 of the FPP) 1.5168 mg,Hypromellose 5 cP (for Placebo of the FPP) 1.0112 mg,Lactose monohydrate (for Phase 1 of the FPP) 48.360 mg,Lac	Bayer AG, Berlin	Registered/Compliant	Details →

Norigynon

TAN 00,4244 G03A N.V Estradiol valerate 5 mg/5.26ml,Norethisterone Enantate 50 mg/5.26ml

Details

Qlaira

TAN 26 HM 0471 Dienogest (Light yellow tablets) 3 mg,Dienogest (medium red tablets) 2 mg,Dienogest, micronized (for Phase 2 of the FPP) 2.000 mg,Dienogest, micronized (for Phase 3 of the FPP) 3.000 mg,Estradiol valerate (Dark red tablets) 1 mg,Estradiol valerate (Light yellow tablets) 2 mg,Estradiol valerate (dark yellow tablets) 3 mg,Estradiol valerate (medium red tablets) 2 mg,Estradiol valerate, micronized (for Phase 1 of the FPP) 3.000 mg,Estradiol valerate, micronized (for Phase 2 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 3 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 4 of the FPP) 1.000 mg,Ferric oxide, red (for Phase 2 of the FPP) 0.03906 mg,Ferric oxide, red (for Phase 4 of the FPP) 0.3651 mg,Ferric oxide, yellow (for Phase 1 of the FPP) 0.2920 mg,Ferric oxide, yellow (for Phase 3 of the FPP) 0.03906 mg,Hypromellose 5 cP (for Phases 1, 2, 3 and 4 of the FPP) 1.5168 mg,Hypromellose 5 cP (for Placebo of the FPP) 1.0112 mg,Lactose monohydrate (for Phase 1 of the FPP) 48.360 mg,Lac

Details

Elsewhere on MedStatus

"ESTRADIOL VALERATE" also matches these in Tanzania.

Active ingredients

Dienogest (Light yellow tablets) 3 mg,Dienogest (medium red tablets) 2 mg,Dienogest, micronized (for Phase 2 of the FPP) 2.000 mg,Dienogest, micronized (for Phase 3 of the FPP) 3.000 mg,Estradiol valerate (Dark red tablets) 1 mg,Estradiol valerate (Light yellow tablets) 2 mg,Estradiol valerate (dark yellow tablets) 3 mg,Estradiol valerate (medium red tablets) 2 mg,Estradiol valerate, micronized (for Phase 1 of the FPP) 3.000 mg,Estradiol valerate, micronized (for Phase 2 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 3 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 4 of the FPP) 1.000 mg,Ferric oxide, red (for Phase 2 of the FPP) 0.03906 mg,Ferric oxide, red (for Phase 4 of the FPP) 0.3651 mg,Ferric oxide, yellow (for Phase 1 of the FPP) 0.2920 mg,Ferric oxide, yellow (for Phase 3 of the FPP) 0.03906 mg,Hypromellose 5 cP (for Phases 1, 2, 3 and 4 of the FPP) 1.5168 mg,Hypromellose 5 cP (for Placebo of the FPP) 1.0112 mg,Lactose monohydrate (for Phase 1 of the FPP) 48.360 mg,Lac

1 product

Estradiol valerate 5 mg/5.26ml,Norethisterone Enantate 50 mg/5.26ml

1 product